Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024

Stem cells may replace some lost retinal neurons

The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration

New cataract and refractive options from STAAR Surgical could come as early as this year

The AI retinal scanning model will be free to use for all institutions

Two members of the team gave a preview of Geuder’s 2024 spotlight products

As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry

The nonprofit marked a major milestone by announcing a suite of webinars with Heidelberg Engineering

MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.

The diagnostic imaging experts will provide education through the Cybersight platform

In a conversation at ESCRS, the CEO said by 2028, Aurion Biotech hopes to see global registration for its corneal endothelial disease therapies.

Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022

According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.

AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.

At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.